Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC7A4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | ANKRD42 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
mRNA | TNP2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
mRNA | C19orf18 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | HSPA1A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | CCDC14 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | GMPR2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
mRNA | LA16c-306E5.2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
mRNA | ENO2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
mRNA | ARHGAP18 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |